Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled Trials
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled Trials
Authors
Keywords
-
Journal
SCHIZOPHRENIA BULLETIN
Volume 42, Issue 6, Pages 1438-1445
Publisher
Oxford University Press (OUP)
Online
2016-04-17
DOI
10.1093/schbul/sbw043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ambiguous findings concerning potential advantages of depot antipsychotics
- (2015) Peter M. Haddad et al. CURRENT OPINION IN PSYCHIATRY
- Premature Mortality Among Adults With Schizophrenia in the United States
- (2015) Mark Olfson et al. JAMA Psychiatry
- Mortality in Mental Disorders and Global Disease Burden Implications
- (2015) Elizabeth Reisinger Walker et al. JAMA Psychiatry
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- Risk factors for suicide in schizophrenia: systematic review and clinical recommendations
- (2014) D. Popovic et al. ACTA PSYCHIATRICA SCANDINAVICA
- Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort
- (2014) Ulrich Reininghaus et al. SCHIZOPHRENIA BULLETIN
- Excess Early Mortality in Schizophrenia
- (2013) Thomas Munk Laursen et al. Annual Review of Clinical Psychology
- Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia
- (2013) Taishiro Kishimoto et al. JOURNAL OF CLINICAL PSYCHIATRY
- Power failure: why small sample size undermines the reliability of neuroscience
- (2013) Katherine S. Button et al. NATURE REVIEWS NEUROSCIENCE
- Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades — A Danish nationwide study from 1980 to 2010
- (2013) René Ernst Nielsen et al. SCHIZOPHRENIA RESEARCH
- Efficacy and safety of second-generation long-acting injections in schizophrenia
- (2012) Paolo Fusar-Poli et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
- (2012) T. Kishimoto et al. SCHIZOPHRENIA BULLETIN
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs
- (2009) Nancy C. Andreasen et al. BIOLOGICAL PSYCHIATRY
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started